PREVIOUS
✖
Project ANAGRANINF
March 30 , 2024
99 days
202
0
- The Technology Development Board (TDB) has penned an agreement with M/s Peptris Technologies Pvt. Ltd. and the Foundation for Neglected Disease Research (FNDR) recently.
- Under the agreement, the Board has sanctioned a grant of ₹75 Lakhs towards the project "ANAGRANINF - Development of a Novel Class of Antibiotics Against Gram-Negative Bacterial-Infections,"
- It aims to develop a novel lead compound, particularly an antibiotic, adept at inhibiting the FabI enzyme and combatting critical gram-negative pathogens.
Leave a Reply
Your Comment is awaiting moderation.